Director of Scientific Affairs The Binding Site, Inc. San Diego, CA Primary Immunodeficiency Diseases (PID) are inborn, genetic disorders with defects in one or more components of the immune system. There are over 180 disease states associated with PID, and they are often underdiagnosed due to the level of severity of the immune dysfunction. Categories of PID, the various methods of testing involved, and economic impact of lack of diagnosis will be discussed. Objectives: Identify the difference between primary and secondary immunodeficiency and define categories of Primary Immunodeficiency Diseases (PID). Describe testing methodology for determining presence of a PID. Discuss potential economic impact of lack of diagnosis of a PID. Workshop #4 Basic Wednesday, May 16 8:00 9:30 am 1.5 Contact Hours – Subject Area General – Why Knowing Now Matters in the Emergency Department Dr. Ellis Jacobs, PhD, DABCC, FACB Director, Scientific Affairs Abbott Rapid Diagnostics There have been significant increases in emergency room visits across the US and delays in the ED leads to poor outcomes. There is an association between waiting times and short-term mortality and hospital admission. Laboratory turnaround time can impact ED operations and, based on simulation modeling, the best performance is predicted when the TAT is 40 minutes or less. The needs of every ED are different and this presentation will look at the impact of Point of Care testing on the provision of medical care and ED operations in three clinical conditions: chest pain (cardiac), sepsis (critical care) and infectious diseases. Objectives: Understand the association between ED waiting times and short-term mortality and hospital admissions. Describe the operational benefits that can be achieved with a rapid chest pain disposition protocol. Understand the role of lactate in the identification and monitoring of sepsis. Explain the impact on key ED operational metrics of rapid infectious disease testing. Workshop #5 Intermediate Wednesday, May 16 10:00 11:30 am 1.5 Contact Hours – Subject Area Blood Bank – Using Molecular Testing to Improve Transfusion Therapy Dr. Ingrid Perez-Alvarez, MD Assistant Professor of Pathology
Director of Scientific Affairs The Binding Site, Inc. San Diego, CA Primary Immunodeficiency Diseases (PID) are inborn, genetic disorders with defects in one or more components of the immune system. There are over 180 disease states associated with PID, and they are often underdiagnosed due to the level of severity of the immune dysfunction. Categories of PID, the various methods of testing involved, and economic impact of lack of diagnosis will be discussed. Objectives: Identify the difference between primary and secondary immunodeficiency and define categories of Primary Immunodeficiency Diseases (PID). Describe testing methodology for determining presence of a PID. Discuss potential economic impact of lack of diagnosis of a PID. Workshop #4 Basic Subject Area – General Wednesday, May 16 8:00 – 9:30 am 1.5 Contact Hours Why Knowing Now Matters in the Emergency Department Dr. Ellis Jacobs, PhD, DABCC, FACB Director, Scientific Affairs Abbott Rapid Diagnostics There have been significant increases in emergency room visits across the US and delays in the ED leads to poor outcomes. There is an association between waiting times and short-term mortality and hospital admission. Laboratory turnaround time can impact ED operations and, based on simulation modeling, the best performance is predicted when the TAT is 40 minutes or less. The needs of every ED are different and this presentation will look at the impact of Point of Care testing on the provision of medical care and ED operations in three clinical conditions: chest pain (cardiac), sepsis (critical care) and infectious diseases. Objectives: Understand the association between ED waiting times and short-term mortality and hospital admissions. Describe the operational benefits that can be achieved with a rapid chest pain disposition protocol. Understand the role of lactate in the identification and monitoring of sepsis. Explain the impact on key ED operational metrics of rapid infectious disease testing. Workshop #5 Intermediate Subject Area – Blood Bank Wednesday, May 16 10:00 – 11:30 am 1.5 Contact Hours Using Molecular Testing to Improve Transfusion Therapy Dr. Ingrid Perez-Alvarez, MD Assistant Professor of Pathology
HCLC+2018+Brochure.docx